Recruiting Atopic Dermatitis Studies in Boardman
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-severe AD who have completed treatment in an A...
A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)
The purpose of this study is to evaluate how well JNJ-95475939 works as compared to placebo in participants with moderate to severe atopic dermatitis....
About Atopic Dermatitis Clinical Trials in Boardman
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Boardman, OH. These studies are seeking a combined 590 participants. Research is being sponsored by Apogee Therapeutics, Inc., Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Boardman — FAQ
Are there atopic dermatitis clinical trials in Boardman?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Boardman, OH. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boardman?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boardman research site will contact you about next steps.
Are clinical trials in Boardman free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boardman studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Boardman are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated March 2, 2026 from ClinicalTrials.gov